ADJUVANT REGORAFENIB IN STAGE IV COLORECTAL CANCER (CRC) AFTER CURATIVE TREATMENT OF LIVER METASTASES: A PHASE III RANDOMIZED, PLACEBO-CONTROLLED STUDY (COAST)

被引：0
|
作者：
Eric, Van Cutsem [1 ]
Takayuki, Yoshino [2 ]
Xu Rui-Hua [3 ]
John, Zalcberg [4 ]
Daniel, Sargent [5 ,6 ]
Michael, Choti [7 ]
Mark, Rutstein [8 ]
Lisa, Cupit [8 ]
Iris, Kuss [9 ]
Axel, Grothey [10 ]
机构：
[1] UZ Leuven, Leuven Canc Inst, Leuven, Belgium
[2] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan
[3] Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China
[4] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[5] Mayo Clin, Rochester, MN USA
[6] Mayo Canc Ctr, Rochester, MN USA
[7] UT Southwestern Med Ctr, Dallas, TX USA
[8] Bayer Healthcare, Whippany, NJ USA
[9] Bayer Pharma AG, Berlin, Germany
[10] Mayo Clin, Coll Med, Div Med Oncol, Rochester, MN USA
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
D O I：
10.1093/annonc/mdu165.261
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P - 0266
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [1] IMPACT OF ADJUVANT CHEMOTHERAPY AFTER CURATIVE RESECTION OF STAGE IV COLORECTAL CANCER EXCLUDING LIVER METASTASIS.
    Asari, M.
    Yamaguchi, S.
    Obara, N.
    Wang, L.
    Kato, T.
    Hara, K.
    Kondo, H.
    Ishii, T.
    Hirano, Y.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E427 - E427
  • [2] Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma
    Hauschild, Axel
    Agarwala, Sanjiv S.
    Trefzer, Uwe
    Hogg, David
    Robert, Caroline
    Hersey, Peter
    Eggermont, Alexander
    Grabbe, Stephan
    Gonzalez, Rene
    Gille, Jens
    Peschel, Christian
    Schadendorf, Dirk
    Garbe, Claus
    O'Day, Steven
    Daud, Adil
    White, J. Michael
    Xia, Chenghua
    Patel, Kiran
    Kirkwood, John M.
    Keilholz, Ulrich
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (17) : 2823 - 2830
  • [3] Adjuvant MUC vaccination with tecemotide after resection of colorectal liver metastases: a randomized, double-blind, placebo-controlled, multicenter AIO phase II trial (LICC)
    Schimanski, Carl Christoph
    Kasper, Stefan
    Hegewisch-Becker, Susanna
    Schroeder, Jan
    Overkamp, Friedrich
    Kullmann, Frank
    Bechstein, Wolf Otto
    Voehringer, Matthias
    Oellinger, Robert
    Lordick, Florian
    Heinemann, Volker
    Geissler, Michael
    Schulz-Abelius, Armin
    Bernhard, Helga
    Schoen, Michael R.
    Greil, Richard
    Galle, Peter
    Lang, Hauke
    Schmidtmann, Irene
    Moehler, Markus
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [4] Early liver metastases after "failure" of adjuvant chemotherapy for stage III colorectal cancer: is there a role for additional adjuvant therapy?
    Boerner, Thomas
    Zambirinis, Constantinos
    Gagniere, Johan
    Chou, Joanne F.
    Gonen, Mithat
    Kemeny, Nancy E.
    Cercek, Andrea
    Connell, Louise C.
    Kingham, Thomas P.
    Allen, Peter J.
    Balachandran, Vinod P.
    Drebin, Jeffrey
    Jarnagin, William R.
    D'Angelica, Michael, I
    HPB, 2021, 23 (04) : 601 - 608
  • [5] Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside for the prevention of oxaliplatin-induced peripheral neurotoxicity in stage II/III colorectal cancer
    Wang, De-shen
    Wang, Zhi-qiang
    Chen, Gong
    Peng, Jie-wen
    Wang, Wei
    Deng, Yan-hong
    Wang, Feng-hua
    Zhang, Jian-wei
    Liang, Han-lin
    Feng, Fen
    Xie, Chuan-bo
    Ren, Chao
    Jin, Ying
    Shi, Si-mei
    Fan, Wen-hua
    Lu, Zhen-hai
    Ding, Pei-rong
    Wang, Feng
    Xu, Rui-hua
    Li, Yu-hong
    CANCER MEDICINE, 2020, 9 (01): : 151 - 159
  • [6] ADJUVANT INTRAPERITONEAL 5-FLUOROURACIL AND INTRAVENOUS LEUCOVORIN AFTER COLORECTAL-CANCER SURGERY - A RANDOMIZED PHASE-II PLACEBO-CONTROLLED STUDY
    GRAF, W
    WESTLIN, JE
    PAHLMAN, L
    GLIMELIUS, B
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 1994, 9 (01) : 35 - 39
  • [7] VIVA trial: A randomized phase II study of adjuvant regorafenib plus durvalumab in stage IV colorectal cancer patients achieving the no evidence of disease state
    Pastorino, A.
    Puccini, A.
    Martelli, V.
    Grassi, M.
    Cremante, M.
    Gandini, A.
    Puglisi, S.
    Catalano, F.
    Murianni, V.
    Pessino, A.
    Andretta, V.
    Mammoliti, S.
    Sciallero, M. S.
    Comandini, D.
    Fornarini, G.
    Caprioni, F.
    Bregni, G.
    Barni, S.
    Labianca, R.
    Sobrero, A. F.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S738 - S738
  • [8] Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)
    Rapp, Stephen R.
    Dressler, Emily V.
    Brown, W. Mark
    Wade, James L.
    Le-Lindqwister, Nguyet
    King, David
    Rowland, Kendrith M.
    Weaver, Kathryn E.
    Klepin, Heidi D.
    Shaw, Edward G.
    Lesser, Glenn J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (21) : 2546 - 2557
  • [9] Aspirin after standard adjuvant therapy for colorectal cancers (ASCOLT): An international, phase III, randomised, placebo-controlled trial
    Chia, J. W. K.
    Segelov, E.
    Deng, Y.
    Wang, W.
    Ho, G. F.
    Sharma, A.
    Ding, K.
    Chen, G.
    Jeffery, G. M.
    Nott, L. M.
    Zielinski, R.
    Ahn, J. B.
    Chao, T. Y.
    Yau, T.
    Nabilah, S.
    Gandhi, M.
    Rothwell, P.
    Simes, J.
    Ali, R.
    Toh, H. C.
    ANNALS OF ONCOLOGY, 2023, 34 : S1269 - S1269
  • [10] Phase III randomized, placebo-controlled, double-blind study of monosialotetrahexosylganglioside in prevention of oxaliplatin-induced neurotoxicity in stage II/III colorectal cancer patients.
    Li, Yu-hong
    Wang, De-Shen
    Wang, Zhiqiang
    Peng, Jie-wen
    Wang, Wei
    Feng, Fen
    Deng, Yanhong
    Zhang, Jianwei
    Wang, Fenghua
    Ren, Chao
    Wang, Feng
    Jin, Ying
    Xie, Chuanbo
    Tan, Qiong
    Chen, Gong
    Xu, Rui-hua
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
12345